Allergy Immunotherapy Market Research Report: Information, by Allergy Type (Allergic Rhinitis, Allergic Asthma, Peanut Allergy, Cat Allergy and others), Treatment (Sublingual Immunotherapy, Subcutaneous Immunotherapy (SCIT) and Specific Immunotherapy (SIT)) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027
ID: MRFR/Pharma/0988-CR | August 2019 | Region: Global | 88 Pages
1 Report Prologue
2 Market Introduction
2.1 Introduction 18
2.2 Scope of Study 18
2.3 Research Objective 19
2.4 Assumptions & Limitations 19
2.4.1 Assumptions 19
2.4.2 Limitations 19
2.5 Market Structure 20
3 Research Methodology
3.1 Research Process 21
3.2 Primary Research 22
3.3 Secondary Research 22
3.4 Market Size Estimation 22
3.5 Forecast Model 24
4 Market Dynamics
4.1 Introduction 25
4.2 Drivers 25
4.2.1 Launch of New sublingual Immunotherapies in emerging Economies will Drive the Growth of the Market 25
4.2.2 Major Players are introducing Several Allergen Immunotherapy Tablets (AITs) in Potential Markets 26
4.2.3 Increase in risk Factors Causing Allergies 26
4.2.4 Rising Screening for Allergy and reimbursement Scenario 26
4.3 Restraint 27
4.3.1 Restricted Healthcare Spending in underserved Market of Europe will Restrain the Growth 27
4.4 Opportunity 27
4.4.1 Allergy Immune Therapies will be Launched in the US. 27
4.5 Challenges 28
4.5.1 High Cost of Allergy Immunotherapy 28
4.6 Micro Economic Indicators 28
5 Market Factor Analysis
5.1 Porter’s Five Forces Model 30
5.1.1 Bargaining Power of Suppliers 31
5.1.2 Bargaining Power of Buyers 31
5.1.3 Threat of New Entrants 31
5.1.4 Threat of Substitutes 31
5.1.5 Intensity of Rivalry 31
5.2 Supply Chain Analysis 32
5.2.1 R&D 32
5.2.2 Parts Manufacturing 33
5.2.3 Distribution 33
5.2.4 Marketing & Sales 33
5.2.5 Post-Sales Monitoring 33
5.3 Pricing Analysis 33
5.4 Investment Opportunity Analysis 34
5.5 Merger and Acquisition Landscape 35
6 Allergy Immunotherapy Market, by Type of Therapy
6.1 Subcutaneous Immunotherapy (SCIT) 37
6.2 Sublingual Immunotherapy (SLIT) 38
7 Allergy Immunotherapy Market, by Types Of Allergies
7.1 Rhinitis 40
7.2 Asthma 40
7.3 Eye Allergy 41
7.4 Skin Allergy 41
8 Allergy Immunotherapy Market, by End User
8.1 Hospitals 43
8.2 Clinics 43
8.3 Diagnostic Centers 44
9 Global Allergy immunotherapy Market, by Region
9.1 Americas 46
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.1 North America 48
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.1.1 US 51
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.1.2 Canada 53
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2 Latin America 55
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.1 Brazil 57
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.2 Mexico 59
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.3 Argentina 61
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.4 Columbia 63
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.5 Chile 64
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.6 Rest of Latin America 66
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3 South America 67
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3.1 Bolivia 70
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3.2 Ecuador 73
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3.3 Peru 75
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3.4 Venezuela 77
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3.5 Uruguay 78
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2 Europe 80
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1 Western Europe 82
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.1 Germany 84
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.2 France 86
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.3 UK 88
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.4 Italy 90
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.5 Spain 92
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.6 Russia 94
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.7 Rest of Western Europe 96
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.2 Central Europe 97
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.2.1 Switzerland 99
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.2.2 Slovenia 101
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.3 Eastern Europe 103
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.4 Greece 105
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.5 Rest of Eastern Europe 107
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3 Asia-Pacific 109
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.1 Japan 111
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.2 China 113
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.3 India 115
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.4 South Korea 117
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.5 Australia 118
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.6 New Zealand 120
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.4 Middle East & Africa 121
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.5 Middle East 124
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.6 Africa 125
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
10 Company Landscape
10.1 Introductions 127
11 Company Profile
11.1 ALK Abello A/S 129
11.1.1 Overview 129
11.1.2 Product/Business Overview 129
11.1.3 Financial Overview 129
11.1.4 Key Development 131
11.1.5 SWOT Analysis 131
11.2 Allergy Therapeutics 132
11.2.1 Company Overview 132
11.2.2 Product/Business Segment Overview 132
11.2.3 Financial Overview 132
11.2.4 Key Development 133
11.2.5 SWOT Analysis 134
11.3 Circassia 135
11.3.1 Company Overview 135
11.3.2 Product/Business Segment Overview 135
11.3.3 Financial Overview 135
11.3.4 Key Development 136
11.3.5 SWOT Analysis 137
11.4 DBV Technologies 138
11.4.1 Company Overview 138
11.4.2 Product/Business Segment Overview 138
11.4.3 Financial Overview 138
11.4.4 Key Development 139
11.4.5 SWOT Analysis 139
11.5 Stallergenes Greer 140
11.5.1 Company Overview 140
11.5.2 Product/Business Segment Overview 140
11.5.3 Financial Overview 140
11.5.4 Key Development 142
11.5.5 SWOT Analysis 142
11.6 Merck KGaA (Allergopharma) 143
11.6.1 Company Overview 143
11.6.2 Product/Business Segment Overview 143
11.6.3 Financial Overview 144
11.6.4 Key Development 145
11.6.5 SWOT Analysis 145
11.7 HAL Allergy Group 146
11.7.1 Company Overview 146
11.7.2 Product/Business Segment Overview 146
11.7.3 Financial Overview 146
11.7.4 Key Development 146
11.7.5 SWOT Analysis 147
12 Conclusion
12.1 Key Findings 148
12.1.1 From CEO’s View Point 148
12.2 Key Companies To Watch 148
13 Appendix
13.1 Discussion Blue Print 149
14 List of Tables
TABLE 1 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY USDMILLION 2020–2027 36
TABLE 2 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SUBCUTANEOUS IMMUNOTHERAPY (SCIT) USDMILLION 2020–2027 37
TABLE 3 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SUBLINGUAL IMMUNOTHERAPY USDMILLION 2020–2027 38
TABLE 4 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPES OF ALLERGIES USD MILLION 2020–2027 39
TABLE 5 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR RHINITIS USD MILLION 2020–2027 40
TABLE 6 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR ASTHMA USD MILLION 2020–2027 40
TABLE 7 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR EYE ALLERGY USD MILLION 2020–2027 41
TABLE 8 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SKIN ALLERGY USD MILLION 2020–2027 41
TABLE 9 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 42
TABLE 10 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR HOSPITALS USD MILLION 2020–2027 43
TABLE 11 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR CLINICS USD MILLION 2020–2027 43
TABLE 12 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR DIAGNOSTIC CENTERS USD MILLION 2020–2027 44
TABLE 13 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020–2027 45
TABLE 14 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020–2027 46
TABLE 15 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 47
TABLE 16 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 47
TABLE 17 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 48
TABLE 18 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2020–2027 48
TABLE 19 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 49
TABLE 20 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 50
TABLE 21 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 50
TABLE 22 US ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 51
TABLE 23 US ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 51
TABLE 24 US ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 53
TABLE 25 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 53
TABLE 26 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 54
TABLE 27 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 54
TABLE 28 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2020–2027 55
TABLE 29 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 56
TABLE 30 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 56
TABLE 31 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 57
TABLE 32 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 57
TABLE 33 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 58
TABLE 34 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 58
TABLE 35 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 59
TABLE 36 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 59
TABLE 37 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 61
TABLE 38 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 61
TABLE 39 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 62
TABLE 40 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 62
TABLE 41 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 63
TABLE 42 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 63
TABLE 43 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 64
TABLE 44 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 64
TABLE 45 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 65
TABLE 46 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 65
TABLE 47 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 66
TABLE 48 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 66
TABLE 49 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 67
TABLE 50 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2020–2027 67
TABLE 51 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 68
TABLE 52 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 69
TABLE 53 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 69
TABLE 54 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 70
TABLE 55 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 70
TABLE 56 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 72
TABLE 57 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 73
TABLE 58 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 73
TABLE 59 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 75
TABLE 60 PERU ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 75
TABLE 61 PERU ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 76
TABLE 62 PERU ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 76
TABLE 63 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 77
TABLE 64 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 77
TABLE 65 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 78
TABLE 66 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 78
TABLE 67 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 79
TABLE 68 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 79
TABLE 69 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020–2027 80
TABLE 70 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 81
TABLE 71 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 81
TABLE 72 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 82
TABLE 73 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2020–2027 82
TABLE 74 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 83
TABLE 75 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 84
TABLE 76 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 84
TABLE 77 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 85
TABLE 78 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 85
TABLE 79 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 86
TABLE 80 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 86
TABLE 81 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 87
TABLE 82 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 87
TABLE 83 UK ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 88
TABLE 84 UK ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 88
TABLE 85 UK ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 90
TABLE 86 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 90
TABLE 87 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 91
TABLE 88 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 91
TABLE 89 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 92
TABLE 90 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 92
TABLE 91 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 94
TABLE 92 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 94
TABLE 93 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 95
TABLE 94 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 95
TABLE 95 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 96
TABLE 96 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 96
TABLE 97 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 97
TABLE 98 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS USD MILLION 2020–2027 97
TABLE 99 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 98
TABLE 100 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 99
TABLE 101 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 99
TABLE 102 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 100
TABLE 103 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 100
TABLE 104 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 100
TABLE 105 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 101
TABLE 106 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 102
TABLE 107 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 102
TABLE 108 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS USD MILLION 2020–2027 103
TABLE 109 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 103
TABLE 110 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 104
TABLE 111 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 104
TABLE 112 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 105
TABLE 113 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 105
TABLE 114 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 107
TABLE 115 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 107
TABLE 116 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 108
TABLE 117 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 108
TABLE 118 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020–2027 109
TABLE 119 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 110
TABLE 120 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 110
TABLE 121 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 111
TABLE 122 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 111
TABLE 123 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 112
TABLE 124 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 112
TABLE 125 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 113
TABLE 126 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 113
TABLE 127 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 115
TABLE 128 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 115
TABLE 129 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 116
TABLE 130 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 116
TABLE 131 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 117
TABLE 132 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 117
TABLE 133 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 118
TABLE 134 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 118
TABLE 135 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 119
TABLE 136 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 119
TABLE 137 REST OF ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 120
TABLE 138 NEW ZEALAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 120
TABLE 139 NEW ZEALAND PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 121
TABLE 140 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020–2027 121
TABLE 141 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 122
TABLE 142 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 123
TABLE 143 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 123
TABLE 144 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 124
TABLE 145 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 124
TABLE 146 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 125
TABLE 147 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2020–2027 125
TABLE 148 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2020–2027 126
TABLE 149 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020–2027 126
TABLE 150 ALK-ABELLÓ A/S: KEY DEVELOPMENT 131
TABLE 151 ALLERGY THERAPEUTICS : KEY DEVELOPMENT 133
TABLE 152 CIRCASSIA : KEY DEVELOPMENT 136
TABLE 153 DBV TECHNOLOGIES: KEY DEVELOPMENT 139
TABLE 154 STALLERGENES GREER: KEY DEVELOPMENT 142
TABLE 155 MERCK KGAA: KEY DEVELOPMENT 145
TABLE 156 HAL ALLERGY GROUP: KEY DEVELOPMENT 146
15 List of Figures
FIGURE 1 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY, 2020 (%) 15
FIGURE 2 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY, 2020 (%) 16
FIGURE 3 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS, 2020 (%) 16
FIGURE 4 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION, 2020 (%) 17
FIGURE 5 GLOBAL ALLERGY IMMUNOTHERAPY MARKET: MARKET STRUCTURE 20
FIGURE 6 RESEARCH PROCESS 21
FIGURE 7 PORTERS FIVE FORCES MODEL 30
FIGURE 8 SUPPLY CHAIN: ALLERGY IMMUNOTHERAPY 32
FIGURE 9 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY USD MILLION 2020 & 2027 36
FIGURE 10 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGIES USD MILLION 2020 & 2027 39
FIGURE 11 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2020 & 2027 42
FIGURE 12 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020 & 2027 45
FIGURE 13 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY REGION MARKET SHARE 2020 (%) 46
FIGURE 14 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2020 (%) 49
FIGURE 15 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2020 (%) 55
FIGURE 16 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY MARKET SHARE 2020 (%) 68
FIGURE 17 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020 & 2027 80
FIGURE 18 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2020 (%) 83
FIGURE 19 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS MARKET SHARE 2020 (%) 98
FIGURE 20 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY REGION USDMILLION 2020 & 2027 109
FIGURE 21 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2020 & 2027 122
FIGURE 22 GLOBAL ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 127
FIGURE 23 AMERICAS ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 128
FIGURE 24 EUROPE ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 128
FIGURE 25 ALK-ABELLÓ A/S: RECENT FINANCIAL 129
FIGURE 26 ALK-ABELLÓ A/S: BUSINESS REVENUE MIX (2015) 129
FIGURE 27 ALK-ABELLÓ A/S: GEOGRAPHIC REVENUE MIX 130
FIGURE 28 ALK-ABELLÓ A/S: SWOT ANALYSIS 131
FIGURE 29 ALLERGY THERAPEUTICS : RECENT FINANCIAL 132
FIGURE 30 ALLERGY THERAPEUTICS : GEOGRAPHIC REVENUE MIX 133
FIGURE 31 ALLERGY THERAPEUTICS : SWOT ANALYSIS 134
FIGURE 32 CIRCASSIA : RECENT FINANCIAL 135
FIGURE 33 CIRCASSIA : GEOGRAPHIC REVENUE MIX 136
FIGURE 34 CIRCASSIA : SWOT ANALYSIS 137
FIGURE 35 DBV TECHNOLOGIES: RECENT FINANCIAL 138
FIGURE 36 DBV TECHNOLOGIES: SWOT ANALYSIS 139
FIGURE 37 STALLERGENES GREER: RECENT FINANCIAL 140
FIGURE 38 STALLERGENES GREER: BUSINESS REVENUE MIX (2015) 140
FIGURE 39 STALLERGENES GREER: GEOGRAPHIC REVENUE MIX 141
FIGURE 40 STALLERGENES GREER: SWOT ANALYSIS 142
FIGURE 41 MERCK KGAA: RECENT FINANCIAL 144
FIGURE 42 MERCK KGAA: GEOGRAPHIC REVENUE MIX 144
FIGURE 43 MERCK KGAA: SWOT ANALYSIS 145
FIGURE 44 HAL ALLERGY GROUP: SWOT ANALYSIS 147
Allergy Immunotherapy Market
The Allergy Immunotherapy Market will obtain a CAGR of 10.85 % and a strong valuation of USD 4,324.7 million in the forecasted period from 2020 to 2027.
$4,324.7 million
Market Size
10.85%
CAGR
North America
Dominating Region
2020-2027
Forecast Period
Segmentation
Key Players
- ALK Abello (U.K.)
- Allergy Therapeutics (U.K.)
- Circassia (U.K.)
- DVB Technologies (U.K.)
- HAL Allergy Group (U.K.)
- Merck KGaA Allergopharma (U.K.)
- Stallergenes Greer (U.K.)
Drivers
- Increasing ailments of allergic rhinitis/conjunctivitis
- Allergic asthma
Allergy Immunotherapy Market Overview
The Allergy Immunotherapy Market will obtain a CAGR of 10.85 % and a strong valuation of USD 4,324.7 million in the forecasted period from 2020 to 2027. Allergic immunotherapy treats allergic asthma, allergic rhinitis/conjunctivitis, and severe insect susceptibility. It also includes daily doses of sublingual immunotherapy, a newly launched immunotherapy in various economies, and the presence of industrial players that will drive the market’s growth. Increasing demand for various medicines to treat illness is driving the market growth. To meet demand, companies are working on the research part to develop the medicines they need in the market. In addition, more and more anti-allergic tablets are being produced by the major players on the market.
The allergy immunotherapy market is in the global market as consumers' disposable incomes increase, and they can spend more on allergy-related treatments, which is an opportunity for growth in the allergy immunotherapy market during the forecast period. It's growing tremendously. In addition, increased environmental pollution increased alcohol consumption, and changes in diet and lifestyle have increased skin-related allergies and increased demand for allergic immunotherapy in the global market.
COVID-19 Analysis:
The covid -19 pandemics have hit our business industries and life on a different level. To cope up with this new normal, we have to make the widely analyzed strategies, and there is the need to focus on the cost-effective measures and high production of the products. Analysts are working upon the various reports of other industrial vehicles of how they tackled this disruption, and experts are researching upon these reports to give apt market insights to their clients. Also, because of the lockdown period and post lockdown period, many manufacturing units of the allergy immunotherapy market were shut down, which results in a steep downfall of the revenues along with decreased profit margin.
However, it is expected that the allergy immunotherapy market in the global market will recover from this global pandemic situation by the end of the second quarter and the beginning of the third quarter in the coming year during the forecasted period from 2020 to 2027.
Market Dynamics:
Drivers
The increasing demand for various drugs to treat ailments is adding growth to the market. To cope with the need, the companies are working upon the research part to develop the needed drugs in the market; in addition to this, more and more allergic ailment tablets have been produced by the key market players.
Opportunities
The allergy immunotherapy market is growing tremendously in the global market owing to an increase in personal disposable income of the consumers which enables them to spend more for the allergy-related treatments which act as an opportunity for the growth of the allergy immunotherapy market during the forecasted period. Moreover, increasing levels of pollution, increasing consumption of alcohol, and changing eating habits and lifestyles resulted in more skin-related allergies and hence increased demand for allergy immunotherapy market in the global market.
Restraints
The allergy immunotherapy market is increasing at an alarming rate in the global market but some factors hamper the growth of the allergy immunotherapy market like the side-effects such as skin-related disorders, gastrointestinal and respiratory disorders associated with the treatment hinders the growth of the allergy immunotherapy market in the global market. Another factor that restricts the growth of the allergy immunotherapy market in the global market is the high cost of treatment which is not afforded by everyone.
Value Chain Analysis
Both the supply and the demand for these tablets are increasing in the market, especially with the increasing kidney ailment diseases. With the advancement in technology, skin-related allergies can be cured in every nook and corner of the world as competitive players have established various units for testing and treatment of allergy immunotherapy market in the global market during the forecasted period from 2017 to 2023.
Segment Overview:
The allergy immunotherapy market in the global market has been divided based on the Allergy into various segments:
Allergic rhinitis- is the harmless substances that cause an allergic reaction.
Rhinitis, allergic asthma- it is the condition of sinus, ear condition, and trouble sleeping.
Peanut allergy- it is the allergy to consuming peanuts. It happens when peanuts are considered a harmful substance in the body.
The allergy immunotherapy market in the global market has been divided based on the treatment into various segments:
Sublingual immunotherapy- it is the treatment in which the doses are given in the smaller quantity, which increases the tolerance level of doses and the symptom of allergy is reduced.
Subcutaneous immunotherapy (SCIT)- in this type, the administration of doses gradually increases to which the individual has allergic symptoms.
Specific immunotherapy (SIT)- is the treatment used in dogs and cats; in this type, doses are administered to extract the allergen and reduce the infection in the body.
Regional Analysis -
Based on the report, the allergy immunotherapy market in the global market has been divided based on the region into Europe region, American region, and the Middle East and the Africa regions, and the rest of the world.
- The increased ailments of the chronic diseases in the Europe area is the fueling factor of the growth in the market of the European region which makes it the largest shareholding region of the market.
- The high prevalence of allergic rhinitis & skin allergy makes the American region the second largest contributor to the allergy immunotherapy market.
- The increasing sector of infrastructure and health facilities in allergic treatments makes Europe the fasted growing economy of the Allergy Immunotherapy Market.
- The ailments of nasal allergies are the fueling factor of growth in the middle east Asia region.
Competitive Landscape:
The most prominent market key players in the global market are as follows:
- ALK Abello (U.K.)
- Allergy Therapeutics (U.K.)
- Circassia (U.K.)
- DVB Technologies (U.K.)
- HAL Allergy Group (U.K.)
- Merck KGaA Allergopharma (U.K.)
- Stallergenes Greer (U.K.)
These are the most prominent efficient key players in allergy immunotherapy in the global market and use various strategies to increase their customer base in the global market and make their policies for capturing the foreign market. Also, they do collaboration, mergers, and acquisitions and partnerships to expand their production base in different countries during the forecasted period from 2017 to 2023.
Recent Developments
In June 2022
Intrommune Therapeutics, Inc., a New York-based clinical biotechnology company developing a patient-friendly treatment platform for peanuts and other food allergies, is in the process of INT 301 for adult patients with peanut allergies. Announced amendments to Phase 1 OMEGA clinical trials. This change will extend the patient's study period to 48 weeks and include a maintenance phase. This maintenance period enables safety evaluation after long-term use of INT301.
In June 2022
QHSLab, Inc is a leading physician licensing and management company today focused on providing physicians with tools to leverage proactive, value-based healthcare solutions through new Point of Care technology. Announcing a strategic alliance with Medical License Factory, LLC. AllergiEnd® Digital Health Services for Allergen Diagnosis and Allergen Immunotherapy Products and Clinical Decision Support.
Report Overview:
The global allergy immunotherapy market research report consists of the following aspects:
- Market Overview
- COVID 19 Analysis
- Market Segmentation
- Value Chain Analysis
- Market Segmentation
- Regional Analysis
- Competitive Analysis
- Recent Developments
With the increasing ailments of allergic rhinitis/conjunctivitis, allergic asthma, peanuts allergy, cat allergy, and stinging insect hypersensitivity, and the growing need for astringent tablets, the market is drastically growing to cope with the upsurging demands of the doses.
As we saw, everything has two sides to the coin. If we talk about the Europe region, they considered it an underserved market, and investing in this will be an effort gone in vain, but with the proper research and development, the market will reach the estimated level. The eminent key players in the market are also contributing the great shares and grabbing the opportunity related to the upsurging demand of the market size.
Users
Pharmaceutical companies, contract research manufacturing organizations, research, and development organizations, academic institutes, and many others.
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | USD 4,324.7 Million |
| CAGR | 10.85% |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2028 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Allergy Type, Treatment And Region |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | ALK Abello (UK), Allergy Therapeutic (UK), Circassia (UK), DVB Technologies (UK), (UK), and HAL Allergy Group (UK), Merck KGaA (Allergopharma), Stallergenes Greer (UK) |
| Key Market Opportunities | newly launched immunotherapies |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Allergy Immunotherapy Market is projected to grow at a 10.85%CAGR between 2020-2027.
Notable players profiled in the Allergy Immunotherapy Market include HAL Allergy Group (UK), Merck KGaA (Allergopharma) (UK), Stallergenes Greer (UK), DBV Technologies (UK), Circassia (UK), Allergy Therapeutic (UK), and ALK Abello A/S (UK).
Europe is predicted to spearhead the Allergy Immunotherapy Market.
Allergy Immunotherapy Market is predicted to touch USD 4,324.7 million by 2027.
Restricted healthcare spending may deter market growth.
